Press Release Jun 23 2021
Filed with NSE · · 3 pages · English
Summary by 6ix AI
Cipla Ltd has issued a press release announcing its final approval for a generic version of Brovana® from Sunovion Pharmaceuticals, Inc. Cipla's product is now available for shipping immediately following the approval from the US FDA.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Cipla
- Press Release Jun 15 2021
- Press Release May 24 2021
- Press Release May 20 2021
- Press Release May 14 2021
- Press Release May 10 2021
Later from Cipla
- Press Release Jun 29 2021
- Press Release Aug 05 2021
- Press Release Aug 12 2021
- Press Release Aug 25 2021
- Press Release Oct 04 2021
Follow Cipla into a list and get an email when it puts out news.
Follow Cipla